These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24804756)
1. Opening Fronts in HIV Vaccine Development: Tracking the development of broadly neutralizing antibodies. Gruell H; Klein F Nat Med; 2014 May; 20(5):478-9. PubMed ID: 24804756 [No Abstract] [Full Text] [Related]
4. Broadly Neutralizing Antibodies and the Development of Vaccines. Haynes BF; Bradley T JAMA; 2015 Jun 23-30; 313(24):2419-20. PubMed ID: 26103022 [No Abstract] [Full Text] [Related]
5. New HIV Vaccine Approach Safely Stimulated Rare Precursors to Broadly Neutralizing Antibodies. Suran M JAMA; 2023 Feb; 329(7):527-528. PubMed ID: 36723948 [TBL] [Abstract][Full Text] [Related]
6. HIV Vaccines: One Step Closer. Low MSY; Tarlinton D Trends Mol Med; 2017 Jan; 23(1):1-3. PubMed ID: 27889424 [TBL] [Abstract][Full Text] [Related]
7. HIV neutralizing antibodies reignite interest in vaccine. Waltz E Nat Biotechnol; 2012 Mar; 30(3):204-5. PubMed ID: 22398603 [No Abstract] [Full Text] [Related]
8. Making it to manufacturing. The potential success of broadly neutralizing monoclonal antibodies for HIV prevention, treatment, and possibly even a cure could come at a cost. Dumiak M IAVI Rep; 2014; 18(2):4-7, 17. PubMed ID: 25105201 [No Abstract] [Full Text] [Related]
9. Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning. Kwong PD; Mascola JR; Nabel GJ Nat Rev Immunol; 2013 Sep; 13(9):693-701. PubMed ID: 23969737 [TBL] [Abstract][Full Text] [Related]
10. HIV vaccine design: the neutralizing antibody conundrum. Stamatatos L Curr Opin Immunol; 2012 Jun; 24(3):316-23. PubMed ID: 22595693 [No Abstract] [Full Text] [Related]
11. The 2017 Keystone Symposium on HIV Vaccines. Cottrell CA; Ward AB Hum Vaccin Immunother; 2017 Oct; 13(10):2348-2351. PubMed ID: 28786733 [No Abstract] [Full Text] [Related]
12. Opening Fronts in HIV Vaccine Development: Targeting reservoirs to clear and cure. Siliciano RF Nat Med; 2014 May; 20(5):480-1. PubMed ID: 24804757 [No Abstract] [Full Text] [Related]
13. Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies. Verkoczy L; Kelsoe G; Moody MA; Haynes BF Curr Opin Immunol; 2011 Jun; 23(3):383-90. PubMed ID: 21524897 [TBL] [Abstract][Full Text] [Related]
14. Engineered Expression of Broadly Neutralizing Antibodies Against Human Immunodeficiency Virus. Ahmad M; Ahmed OM; Schnepp B; Johnson PR Annu Rev Virol; 2017 Sep; 4(1):491-510. PubMed ID: 28645240 [TBL] [Abstract][Full Text] [Related]
15. Emerging concepts on the role of innate immunity in the prevention and control of HIV infection. Ackerman ME; Dugast AS; Alter G Annu Rev Med; 2012; 63():113-30. PubMed ID: 22077718 [TBL] [Abstract][Full Text] [Related]
16. HIV vaccine development--improving on natural immunity. Johnston MI; Fauci AS N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447 [No Abstract] [Full Text] [Related]
17. A brief history of the global effort to develop a preventive HIV vaccine. Esparza J Vaccine; 2013 Aug; 31(35):3502-18. PubMed ID: 23707164 [TBL] [Abstract][Full Text] [Related]